|
|
 |
|
 |
August 17, 2005
MDX Medical Announces Board Changes
Vancouver, BC - (August 17, 2005) MDX Medical Inc. (TSX.V: MDX) a leader in the development of non-invasive medical devices, announced today the appointment of Jim Heppell to its Board of Directors. Mr. Jim Heppell is the President and Fund Manager of BC Advantage Fund as well as founding Partner and CEO of Catalyst Corporate Finance Lawyers. Mr Heppell has participated in the development of a number of Life Science companies including, Cardiome Pharma Corp., Forbes Medi-Tech, Inflazyme Pharmaceuticals, Response Biomedical Ltd. Resigning from the MDX Board of Directors is Mr. Kevin Leong, who will retain the Chief Financial Officer position and remain Corporate Secretary. Mr. Jeremy Teraoka and Mr. Ken Phillippe have also resigned to help fulfill the Company�s business objectives.
Mr. Barry Allen, President and CEO of MDX Medical, states "In conjunction with the successful completion of our recent financing, of which BC Advantage Fund was the lead investor, MDX continues to strengthen and build an independent Board of Directors. We welcome the addition of Jim Heppell to our Board of Directors, he brings a wealth of experience and a successful track record building public companies. The resignation of Kevin Leong provides more independence and improved Corporate Governance. The Board thanks Jeremy Teraoka and Ken Phillipe for their outstanding service and contribution to the Company and wish them every success. MDX will continue to make changes to its Board of Directors to assist in the advancement of its strategies and corporate objectives. "
About MDX Medical
MDX Medical Inc.'s focus is on the commercialization of novel, innovative and leading edge medical device technologies for improved diagnosis and treatment of prominent health disorders. The Company�s business strategy is to acquire and commercialize high potential technologies that have reached the "proof of feasibility" or later stages of product development. For more information about MDX, please visit our website at: www.mdxmedical.com.
On behalf of the Board,
"Barry Allen"
President & CEO
MDX Medical Inc.
Certain information contained in this press release may be forward looking and is subject to unknown risks, which could cause actual results to differ materially from those, set forth or implied herein. Although the Company believes that the expectations reflected in such forward looking statements are reasonable, it can give no assurance that such expectations will prove correct.
The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Larry Horsburgh
Phone: (604) 694-7770, Ext. 112
Email: lhorsburgh@mdxmedical.com |
|  |
|
